ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W107. A total of 32 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $342,000 | +182.6% | 972,285 | +56.4% | 0.07% | +38.0% |
| Q1 2020 | $121,000 | -83.0% | 621,840 | -81.0% | 0.05% | -74.7% |
| Q4 2019 | $713,000 | -64.8% | 3,275,718 | -62.8% | 0.20% | -81.8% |
| Q3 2019 | $2,023,000 | -1.5% | 8,797,509 | +5.4% | 1.09% | -57.8% |
| Q2 2019 | $2,053,000 | +40.8% | 8,343,716 | +108.8% | 2.58% | +2866.7% |
| Q1 2018 | $1,458,000 | +4.1% | 3,995,400 | +64.1% | 0.09% | -4.4% |
| Q3 2017 | $1,400,000 | +84.2% | 2,434,103 | +180.2% | 0.09% | +106.8% |
| Q4 2016 | $760,000 | -59.3% | 868,608 | -37.2% | 0.04% | -37.1% |
| Q3 2016 | $1,867,000 | +1443.0% | 1,382,629 | +1920.6% | 0.07% | +1300.0% |
| Q3 2015 | $121,000 | – | 68,427 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 1,590,267 | $915,000 | 0.48% |
| ARMISTICE CAPITAL, LLC | 4,382,000 | $2,520,000 | 0.30% |
| DAFNA Capital Management LLC | 333,000 | $192,000 | 0.12% |
| SABBY MANAGEMENT, LLC | 2,434,103 | $1,400,000 | 0.09% |
| Anson Funds Management LP | 1,024,592 | $589,000 | 0.09% |
| Hartford Financial Management Inc. | 18,000 | $10,000 | 0.01% |
| Summit X, LLC | 11,000 | $7,000 | 0.01% |
| SNS Financial Group, LLC | 18,000 | $10,000 | 0.00% |
| DOWLING & YAHNKE LLC | 22,870 | $13,000 | 0.00% |
| A.R.T. Advisors, LLC | 30,005 | $17,000 | 0.00% |